Myocardial infarction due to coronary thrombosis is a critical medical condition characterized by the formation of a blood clot within the coronary arteries, impeding blood flow to the heart muscle. This obstruction poses a significant threat, often resulting in severe consequences if not promptly addressed. The coronary arteries play a pivotal role in nourishing the heart with oxygen and nutrients, ensuring its optimal function. However, the occurrence of a thrombus within these arteries disrupts this essential blood flow, leading to an insufficient supply of oxygen to the heart. This oxygen deprivation can inflict damage to the heart muscle, culminating in a heart attack. Various risk factors contribute to the development of coronary thrombosis, including atherosclerosis, marked by the accumulation of plaque in the arteries, high blood pressure, and smoking. The interplay of these factors increases the likelihood of thrombus formation and exacerbates the potential for adverse cardiac events. Swift medical intervention is imperative in the face of coronary thrombosis. Treatment modalities include the administration of clot-dissolving medications and invasive procedures like angioplasty, both aimed at restoring normal blood flow and preventing further harm to the heart.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States